Efficacy of targeted lung denervation in patients with moderate to severe COPD

被引：0
|
作者：
Slebos, Dirk-Jan
Klooster, Karin
Koegelenberg, Coenraad
Theron, Johan
Steyn, Dorothy
Mayse, Martin
Bolliger, Chris
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
COPD; -; management; Bronchoscopy; Lung function testing;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1774
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Aclidinium Bromide Improves Static Lung Function And Hyperinflation In Patients With Moderate-To-Severe COPD
    Watz, H.
    Beeh, K.
    Magnussen, H.
    De Teresa, L.
    Jarreta, D.
    Caracta, C.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [42] Sputum microbiota in moderate versus severe patients with COPD
    Galiana, Antonio
    Aguirre, Estefania
    Rodriguez, Juan Carlos
    Mira, Alex
    Santibanez, Miguel
    Candela, Inmaculada
    Llavero, Juana
    Garcinuno, Pedro
    Lopez, Francisco
    Ruiz, Montserrat
    Garcia-Pachon, Eduardo
    Royo, Gloria
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (06) : 1787 - 1790
  • [43] Target Lung Denervation as a new Treatment Option for Patients with COPD
    Krome, Susanne
    PNEUMOLOGIE, 2019, 73 (12): : 710 - 710
  • [44] Renal Denervation in Moderate to Severe CKD
    Hering, Dagmara
    Mahfoud, Felix
    Walton, Antony S.
    Krum, Henry
    Lambert, Gavin W.
    Lambert, Elisabeth A.
    Sobotka, Paul A.
    Boehm, Michael
    Cremers, Bodo
    Esler, Murray D.
    Schlaich, Markus P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (07): : 1250 - 1257
  • [45] Aclidinium Bromide Treatment in Patients Receiving Beta-Blockers: Effects on MACE, Moderate/Severe COPD Exacerbations, and Lung Function in Patients with Moderate-to-Very Severe COPD and Cardiovascular Risk Factors (ASCENT-COPD)
    Chapman, K. R.
    Wise, R. A.
    Scirica, B. M.
    Bhatt, D. L.
    Daoud, S. Z.
    Lythgoe, D.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [46] Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
    Christophe Pison
    Pallav L. Shah
    Dirk-Jan Slebos
    Vincent Ninane
    Wim Janssens
    Thierry Perez
    Romain Kessler
    Gaetan Deslee
    Justin L. Garner
    Jorine E. Hartman
    Bruno Degano
    Anna Mayr
    Martin Mayse
    Alexander D. Peterson
    Arschang Valipour
    Respiratory Research, 22
  • [47] Safety of Denervation Following Targeted Lung Denervation (TLD) Therapy for COPD: Airflow-1 Three Year Outcomes
    Pison, C.
    Shah, P. L.
    Slebos, D.
    Ninane, V.
    Janssens, W.
    Perez, T.
    Kessler, R.
    Deslee, G.
    Garner, J.
    Abele, C.
    Hartman, J. E.
    Valipour, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
    Christophe, Pison
    Pallav, L. Shah
    Dirk-Jan, Slebos
    Vincent, Ninane
    Wim, Janssens
    Thierry, Perez
    Romain, Kessler
    Gaetan, Deslee
    Justin, L. Garner
    Jorine, E. Hartman
    Bruno, Degano
    Anna, Mayr
    Martin, Mayse
    Alexander, D. Peterson
    Arschang, Valipour
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [49] EFFICACY OF ACLIDINIUM BROMIDE COMPARED WITH TIOTROPIUM AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE COPD: A PHASE IIIB STUDY
    Beier, Jutta
    Kirsten, Anne Marie
    Mroz, Robert
    Segarra, Rosa
    Chuecos, Ferran
    Caracta, Cynthia
    Garcia Gil, Esther
    THORAX, 2012, 67 : A26 - A27
  • [50] Assessing efficacy of indacaterol in moderate and severe COPD patients: A 12-week study in an Asian population
    To, Yasuo
    Kinoshita, Masaharu
    Lee, Sang Haak
    Hang, Liang-Wen
    Ichinose, Masakazu
    Fukuchi, Yoshinosuke
    Kitawaki, Tetsuji
    Okino, Naoko
    Prasad, Niyati
    Lawrence, David
    Kramer, Benjamin
    RESPIRATORY MEDICINE, 2012, 106 (12) : 1715 - 1721
12345